The 3,700 samples were sent out beginning last fall, primarily to labs
in the United States, although 14 were in Canada and 61 were in 16 other
countries, Stohr said.
"The people who are handling this are extremely experienced in dealing
with potentially dangerous pathogens, and we have no reason to believe that
there were any breaches," Rutz said. "But there's always a concern about a virus
to which a sizable part of the population has no immunity, and we're interested
in seeing to it that it's neutralized as quickly as possible."
The mistake came to light March 25 when the National Microbiology
Laboratory in Winnipeg, Manitoba, identified the virus. "They were doing this
routine testing and identified this virus and said, 'This shouldn't be here,' "
Rutz said. Canadian officials notified WHO and the CDC on Friday.
"We have requested that additional measures be taken -- that the
laboratories have to acknowledge receipt of the message in written form, to
confirm that they have destroyed any of these samples, and that they would
monitor their laboratory staff for any respiratory disease," Stohr said.
Robert G. Webster, a flu expert at St. Jude's Children's Research
Hospital in Memphis, called the incident "a terrible, terrible mistake."
"I have been telling WHO for a number of years that this is a dangerous
virus that is still out there in more labs than they know," he said. "This may
alert WHO and Homeland Security and whoever wants to know that each and every
H2N2 sample from 1957 needs to be rounded up and locked down."
Neither the College of American Pathologists nor Meridian Bioscience
was aware that the virus being shipped was the deadly 1957 strain, said Jared
Schwartz, a pathologist and spokesman for the college. The college asked the
company to ship a Type A strain of virus, he said, and Meridian's paperwork
indicated that this strain was benign.
"For reasons I don't understand and Meridian doesn't understand, the
documentation they had was incorrect," he said, adding that the source of the
mislabeling was unclear.
Meridian may have obtained the strain from another company that had
misidentified it, he said. Even had Meridian known it was the deadly H2N2
strain, Schwartz said, current federal guidelines would have allowed the company
to ship it. He said that neither the college nor the company was aware CDC was
considering whether to reclassify the strain as too deadly to ship.
Schwartz said a mechanism is being established to require anyone
shipping pathogens to notify the CDC about what strains of virus are
involved.
William J. Motto, chairman and chief executive of Meridian Bioscience,
said he had no comment last night.
Staff writer David Brown and research editor Lucy
Shackelford contributed to this report.